Search Results

ENGLISH

Uterine Cancer - Screening, Diagnosis, And Treatment

135,18€ + 10% CARD

free shipping

 There are more than 63,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009.
ENGLISH

Uterine Cancer - Screening, Diagnosis, And Treatment

131,84€ + 10% CARD

 There are more than 52,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009.
ENGLISH

Hepatocellular Carcinoma - Diagnosis And Treatment

135,18€ + 10% CARD

free shipping

 â€¢ Hepatocellular carcinoma (HCC) used to be regarded as a rare disease.
ENGLISH

Gynecological Cancers - Genetic And Epigenetic Targets And Drug Development

148,70€ + 10% CARD

free shipping

 Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers.
ENGLISH

Intraoperative Irradiation - Techniques And Results

243,33€ + 10% CARD

free shipping

 The rationale for using intraoperative irradiation (IORT) is based on the realization that tolerable doses of eternal beam radiation are often insufficient to achieve control of locally advanced malignancies.
ENGLISH

Molecular Pathology Of Gynecologic Cancer

135,18€ + 10% CARD

free shipping

 This book focuses on putting successful molecular strategies into practice for the treatment of gynecologic cancer. It approaches research into the pathology and treatment of gynecologic oncology from both clinical and experimental perspectives. This new volume will be necessary reading for clinicians and experimental researchers alike.
ENGLISH

Gynecological Cancers - Genetic And Epigenetic Targets And Drug Development

118,59€ + 10% CARD

 Facilitating the collaboration between the basic, translational, and clinical sciences, this book provides an overview of the genetic and epigenetic mechanisms underlying the formation and progression of gynecological cancers.
ENGLISH

Hepatocellular Carcinoma - Diagnosis And Treatment

131,84€ + 10% CARD

 â€¢ Hepatocellular carcinoma (HCC) used to be regarded as a rare disease.
ENGLISH

Hepatocellular Carcinoma - Diagnosis And Treatment

175,73€ + 10% CARD

free shipping

 â€¢ Hepatocellular carcinoma (HCC) used to be regarded as a rare disease.
ENGLISH

Rethinking Engineering Education - The Cdio Approach

by Doris R. Brodeur, Edward F. Crawley, Johan Malmqvist, Kristina Edstrom e Soren Ostlund

148,70€ + 10% CARD

free shipping

 This book describes an approach to engineering education that integrates a comprehensive set of personal, interpersonal, and professional engineering skills with engineering disciplinary knowledge in order to prepare innovative and entrepreneurial engineers.
ENGLISH

Lymphoma - Diagnosis And Treatment

243,33€ + 10% CARD

free shipping

 As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.
ENGLISH

Lymphoma - Diagnosis And Treatment

237,84€ + 10% CARD

 As part of the Current Clinical Oncology series, Lymphoma: Diagnosis and Treatment will be of value to medical oncologists, hematologists, radiation oncologists, and all physicians involved in the care of patients with lymphoid malignancies.
ENGLISH

Rectal Cancer - International Perspectives On Multimodality Management

131,84€ + 10% CARD

 Rectal Cancer: International Perspectives on Multimodality Management is a timely analysis of the diagnosis, staging, pathology, and therapy of cancer of the rectum. This book is intended as a useful resource for physicians, scientists, medical students, and allied health personnel in the disciplines of radiology, gastroenterology, surgical oncology, medical onc- ogy, radiation oncology, and pathology. Renowned contributors from different medical d- ciplines have written their chapters in a thoughtful, provocative, and visual fashion. Importantly, these chapters highlight the controversies in the diagnostic, staging, and the- peutic management of patients with rectal cancer while providing practical management recommendations. This book is divided into 18 chapters. Early chapters address the diagnosis and staging of rectal cancer, highlighting the critical role of contemporary imaging in guiding treatment. The remaining chapters focus on the multimodality management of rectal cancer from the vantage points of surgery, pathology, chemotherapy, and radiation therapy. The major dev- opments in surgery are reviewed first, including contemporary roles of local excision, total mesorectal excision, lateral pelvic lymph node dissection, organ preservation approaches, as well as the management of advanced, recurrent, and metastatic disease. Following is a ch- ter describing the pathologic evaluation of rectal cancer specimens, with emphasis on proper methodology and its clinical relevance to overall disease management. The final chapters review the contemporary roles of chemotherapy (including with radiation therapy, adjuvant and neoadjuvant settings without radiation therapy, as well as in metastatic disease) as well as radiation therapy (including adjuvant and neoadjuvant approaches, short vs.
ENGLISH

Primary Central Nervous System Tumors - Pathogenesis And Therapy

237,84€ + 10% CARD

 As more brain tumor diagnoses are made, physicians in various fields are being called upon to treat patients with brain tumors. This practical, comprehensive and treatment-oriented textbook is aimed at any medical professional involved in their care.
ENGLISH

Hepatocellular Carcinoma - Diagnosis And Treatment

266,33€ + 10% CARD

 Offers information on the developments in the diagnosis and treatment of primary liver cancer. This book details for physicians the diagnostic and therapeutic decision making process for dealing with such problems as incidental tumors in the liver transplant, the role of neo-adjuvant chemotherapy, and intra-arterial vs intravenous therapy.
ENGLISH

From Local Invasion To Metastatic Cancer - Involvement Of Distant Sites Through The Lymphovascular System

237,84€ + 10% CARD

 In From Local Invasion to Metastatic Cancer: Involvement of Distant Sites Through the Lymphovascular System, a panel of international authorities takes an in-depth look at the role of the lymphovascular system in the spread of cancer.
ENGLISH

High-Grade Gliomas - Diagnosis And Treatment

237,84€ + 10% CARD

 This is truly an exciting time in the field of neuro-oncology, particularly in the area of hi- grade gliomas. The management of patients with high-grade gliomas has historically been one of the most challenging and disheartening fields in medicine, where failure is the rule and longevity is the exception. The jaded often state that despite purported advances in surgical and radiotherapeutic techniques and a myriad of clinical trials of medical therapies, the s- vival statistics for glioblastoma have not changed in the last three decades. The nihilism associated with these tumors is such that some practitioners still advise against treatment or even biopsy, recommending palliative care with the diagnosis based only on history and an MRI scan. If the current state-of-the-art in the diagnosis and management of high-grade gliomas was truly so bleak, there would be no reason to compile and publish a monograph on the subject. The fact is that we have recently entered an era where real progress is being made in our understanding and treatment of high-grade gliomas that is directly benefiting some patients. We are slowly but surely chipping away at this problem. One approach has exploited correlations between particular molecular markers and therapeutic response. The first such "breakthrough" in high-grade glioma was the observation that loss of chromosomes 1p and 19q uniformly predict chemosensitivity in anaplastic oligodendrogliomas (1).
ENGLISH

Cancer Immunotherapy At The Crossroads - How Tumors Evade Immunity And What Can Be Done

171,59€ + 10% CARD

 Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.
ENGLISH

Intraoperative Irradiation - Techniques And Results

95,40€ + 10% CARD

 International radiation oncologists, surgeons, and scientists comprehensively review the techniques, indications, and results of using intraoperative electrons (IOERT) and high-dose rate brachytherapy (HDR-IORT). State-of-the-art topics range from methods and techniques of treatment and issues of normal tissue/organ tolerance to IORT, to techniques and results by disease-site, as well as future possibilities. The disease-site chapters cover every body part for which the potential merit of IORT has been demonstrated, with disease-specific treatment factors presented by a radiation oncologist and a surgeon. The diseases range from GI cancers to CNS and breast malignancies. International in authorship and comprehensive in scope, Intraoperative Irradiation: Techniques and Results offers a cutting-edge resource and reference for surgeons, radiation oncologists, physicists, anesthesiologists, medical oncologists, and all others involved in providing IORT and HDR-IORT procedures and cancer care today.
ENGLISH

Current Controversies In Bone Marrow Transplantation

118,59€ + 10% CARD

 Leading transplant physicians critically review and interpret twenty-one key clinical challenges in bone marrow/hematopoietic cell transplantation, and offer their best personal recommendations for treatment.
ENGLISH

Renal Cell Carcinoma - Molecular Biology, Immunology, And Clinical Management

95,40€ + 10% CARD

 Renal cell carcinoma represents a heterogeneous group of tumors, the most common of which is clear cell adenocarcinoma. The annual incidence of this tumor appears to be rising and approximately 12,000 individuals die from this cancer annually in the United States. One third of patients who present have metastatic disease at the time of diagnosis, and another 40% who undergo nephrectomy will ultimately develop this complication. Over the past 10 years, a significant amount of new information concerning the epidemiology, mole- lar and immunologic characteristics, and therapy for patients with these tumors has appeared. The recognition that inherited forms of renal cancer exist, and that chromosomal abn- malities can be identified in these tumors, suggested a genetic basis for renal cell carcinoma. The familial cancer syndrome, Von Hippel Lindau disease, provided the setting in which the genetic abnormalites associated with the development of renal cancer were first described. Abnormalities of the VHL gene have also been detected in sporadic clear cell carcinoma, and it has now been recognized that approximately 80 % of these tumors will demonstrate ch- acteristic alterations. Currently the functions of the VHL protein are being investigated, and the biology of clear cell carcinoma of the kidney is under study. Additionally, papillary carcinomas of the kidney appear to express different molecular defects, and these are now being unraveled.
ENGLISH

Regional Chemotherapy - Clinical Research And Practice

131,84€ + 10% CARD

 Maurie Markman and a panel of distinguished clinicians and leading clinical investigators comprehensively review the current status of regional antineoplastic drug delivery in the management of malignant disease.
ENGLISH

Colorectal Cancer - Multimodality Management

237,84€ + 10% CARD

 The rapid growth in the number of options available for the management of colorectal cancer presents the clinician with new opportunities and new complexities.
ENGLISH

Melanoma - Biologically Targeted Therapeutics

59,61€ + 10% CARD

 Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or celÂ lular protein targets are those of greatest potential for further reducing mortality from melanoma.
Loading results...

View more results